We are live on ! Find out more
RLAY icon

Relay Therapeutics

115 hedge funds and large institutions have $3.64B invested in Relay Therapeutics in 2020 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

191% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 11

60% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 20

22% more funds holding

Funds holding: 94115 (+21)

0% more funds holding in top 10

Funds holding in top 10: 1111 (0)

0% less capital invested

Capital invested by funds: $3.64B → $3.64B (-$155K)

2.91% less ownership

Funds ownership: 100.36%97.46% (-2.9%)

Holders
115
Holders Change
+21
Holders Change %
+22.34%
% of All Funds
2.03%
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.19%
New
32
Increased
32
Reduced
20
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
51
Millennium Management
New York
$2.9M +$3.15M +69,695 New
Citadel Advisors
52
Citadel Advisors
Florida
$2.62M +$403K +8,904 +16%
Swiss National Bank
53
Swiss National Bank
Switzerland
$2.54M +$2.76M +61,000 New
CS
54
Credit Suisse
Switzerland
$2.13M +$2.32M +51,223 New
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$2.02M
California Public Employees Retirement System
56
California Public Employees Retirement System
California
$1.93M -$40.7K -900 -2%
State of Wisconsin Investment Board
57
State of Wisconsin Investment Board
Wisconsin
$1.89M -$253K -5,600 -11%
Ameriprise
58
Ameriprise
Minnesota
$1.84M -$69.3K -1,532 -3%
Tudor Investment Corp
59
Tudor Investment Corp
Connecticut
$1.8M +$1.08M +23,939 +124%
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$1.68M +$170K +3,771 +10%
SFI
61
Susquehanna Fundamental Investments
Pennsylvania
$1.32M -$318K -7,037 -18%
APM
62
Avidity Partners Management
Texas
$1.25M
New York State Common Retirement Fund
63
New York State Common Retirement Fund
New York
$1.21M
DekaBank Deutsche Girozentrale
64
DekaBank Deutsche Girozentrale
Germany
$1.13M +$1.21M +26,700 New
Deutsche Bank
65
Deutsche Bank
Germany
$1.04M +$358K +7,922 +46%
EAM
66
Erste Asset Management
Austria
$980K +$1.04M +23,100 New
SG Americas Securities
67
SG Americas Securities
New York
$977K +$1.06M +23,504 New
Wells Fargo
68
Wells Fargo
California
$964K -$443K -9,810 -30%
PPA
69
Parametric Portfolio Associates
Washington
$895K +$310K +6,868 +47%
BFO
70
Boston Family Office
Massachusetts
$878K
ProShare Advisors
71
ProShare Advisors
Maryland
$873K +$950K +21,014 New
Manulife (Manufacturers Life Insurance)
72
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$822K +$98.9K +2,187 +12%
TD Asset Management
73
TD Asset Management
Ontario, Canada
$762K
CSS
74
Cubist Systematic Strategies
Connecticut
$682K +$85K +1,881 +13%
HS
75
HighVista Strategies
Massachusetts
$622K +$677K +14,975 New

RLAY Hedge Fund Activity: Q4 2020 in Review

115 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Relay Therapeutics (RLAY) for Q4 2020, worth a combined $3.64B — down 0% from $3.64B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new RLAY positions and 11 closed out — a net gain of 21 holders — while 32 added to existing stakes and 20 trimmed.

The largest buyer was BlackRock, adding an estimated $49.3M. The largest seller was Baillie Gifford & Co, cutting an estimated $252M.

  • 115 institutional investors held Relay Therapeutics (RLAY) as of Q4 2020, up from 94 in Q3 2020.
  • Funds reported $3.64B of Relay Therapeutics stock for Q4 2020, down 0% quarter-over-quarter.
  • 32 funds opened new Relay Therapeutics positions in Q4 2020 and 11 closed out, a net change of +21 holders.
  • The largest Relay Therapeutics buyer in Q4 2020 was BlackRock, an estimated $49.3M added.
  • The largest Relay Therapeutics seller in Q4 2020 was Baillie Gifford & Co, an estimated $252M sold.

Based on aggregated 13F filings for Q4 2020.